首页 > 最新文献

Annals of Surgical Treatment and Research最新文献

英文 中文
Single-nucleotide polymorphisms of donor CYP3A5 and recipient ABCB1 affect tacrolimus intrapatient variability in living donor liver transplantation: a retrospective cohort study. 活体肝移植中供体CYP3A5和受体ABCB1单核苷酸多态性影响他克莫司患者内变异性:一项回顾性队列研究
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2025-10-01 DOI: 10.4174/astr.2025.109.4.252
Saran Ochir Gongor, Kwang-Woong Lee, Eun-Woo Choi, Jae-Yoon Kim, Jeong-Moo Lee, Suk Kyun Hong, YoungRok Choi, Nam-Joon Yi, Kyung-Suk Suh

Purpose: The relationship between tacrolimus intrapatient variability (IPV) and its metabolism-associated single-nucleotide polymorphisms (SNPs) in liver transplantation (LT) remains unclear. Moreover, the influence of donor SNP on recipient IPV is poorly understood. Our objective was to investigate how SNPs affect tacrolimus IPV by analyzing both donor and recipient SNP data in LT.

Methods: This retrospective study examined the association between tacrolimus IPV and eight specific SNPs in 50 adult LT recipients and 50 LT donors genotyped for CYP3A5, ABCB1, ABCC2, and POR genes and their SNPs. Recipients were divided into high IPV (≥30) and low IPV (<30) groups based on 3-12 months after LT IPV calculations. Multivariate logistic regression was used to identify risk factors for high IPV. Post-LT long-term outcomes were also compared between the groups.

Results: Two SNPs were significantly associated with high IPV in multivariate analysis. Recipient ABCB1 1236C>T genotypes CT and CC (odds ratio [OR], 13.969; 95% confidence interval [CI], 1.738-112.300; P = 0.013), donors' CYP3A5 6986A>G genotypes GA and GG (OR, 4.390; 95% CI, 1.005-19.178; P = 0.049), and glucose ≥120 mg/dL at 3 months (OR, 6.494; 95% CI, 1.300-32.168; P = 0.024) were associated with high IPV. However, post-LT long-term outcomes were similar between the groups.

Conclusion: SNPs of donor CYP3A5 and recipient ABCB1 can significantly influence tacrolimus IPV in patients undergoing living donor LT. Identifying these SNPs can help determine high IPV-prone patients, facilitate close monitoring of high IPV-susceptible groups, and improve outcomes.

目的:肝移植(LT)中他克莫司患者内变异性(IPV)与其代谢相关单核苷酸多态性(snp)之间的关系尚不清楚。此外,供体SNP对受体IPV的影响尚不清楚。我们的目的是通过分析LT供体和受体SNP数据来研究SNP是如何影响他克莫司IPV的。方法:本回顾性研究检测了50名成年LT受体和50名LT供体CYP3A5、ABCB1、ABCC2和POR基因分型的8个特异性SNP与他克莫司IPV之间的关系。将受者分为高IPV组(≥30)和低IPV组(结果:多因素分析显示,两个snp与高IPV显著相关。受体ABCB1 1236C>T基因型CT和CC(优势比[OR], 13.969; 95%可信区间[CI], 1.738 ~ 112.300; P = 0.013)、供体CYP3A5 6986A>G基因型GA和GG(优势比,4.390;95% CI, 1.005 ~ 19.178; P = 0.049)、3个月时血糖≥120 mg/dL(优势比,6.494;95% CI, 1.300 ~ 32.168; P = 0.024)与高IPV相关。然而,两组间术后的长期结果相似。结论:供体CYP3A5和受体ABCB1 snp可显著影响活体供体lt患者他克莫司IPV,识别这些snp有助于确定ipvv高易发患者,便于密切监测ipvv高易感人群,改善预后。
{"title":"Single-nucleotide polymorphisms of donor <i>CYP3A5</i> and recipient <i>ABCB1</i> affect tacrolimus intrapatient variability in living donor liver transplantation: a retrospective cohort study.","authors":"Saran Ochir Gongor, Kwang-Woong Lee, Eun-Woo Choi, Jae-Yoon Kim, Jeong-Moo Lee, Suk Kyun Hong, YoungRok Choi, Nam-Joon Yi, Kyung-Suk Suh","doi":"10.4174/astr.2025.109.4.252","DOIUrl":"10.4174/astr.2025.109.4.252","url":null,"abstract":"<p><strong>Purpose: </strong>The relationship between tacrolimus intrapatient variability (IPV) and its metabolism-associated single-nucleotide polymorphisms (SNPs) in liver transplantation (LT) remains unclear. Moreover, the influence of donor SNP on recipient IPV is poorly understood. Our objective was to investigate how SNPs affect tacrolimus IPV by analyzing both donor and recipient SNP data in LT.</p><p><strong>Methods: </strong>This retrospective study examined the association between tacrolimus IPV and eight specific SNPs in 50 adult LT recipients and 50 LT donors genotyped for <i>CYP3A5</i>, <i>ABCB1</i>, <i>ABCC2</i>, and <i>POR</i> genes and their SNPs. Recipients were divided into high IPV (≥30) and low IPV (<30) groups based on 3-12 months after LT IPV calculations. Multivariate logistic regression was used to identify risk factors for high IPV. Post-LT long-term outcomes were also compared between the groups.</p><p><strong>Results: </strong>Two SNPs were significantly associated with high IPV in multivariate analysis. Recipient <i>ABCB1</i> 1236C>T genotypes CT and CC (odds ratio [OR], 13.969; 95% confidence interval [CI], 1.738-112.300; P = 0.013), donors' <i>CYP3A5</i> 6986A>G genotypes GA and GG (OR, 4.390; 95% CI, 1.005-19.178; P = 0.049), and glucose ≥120 mg/dL at 3 months (OR, 6.494; 95% CI, 1.300-32.168; P = 0.024) were associated with high IPV. However, post-LT long-term outcomes were similar between the groups.</p><p><strong>Conclusion: </strong>SNPs of donor <i>CYP3A5</i> and recipient <i>ABCB1</i> can significantly influence tacrolimus IPV in patients undergoing living donor LT. Identifying these SNPs can help determine high IPV-prone patients, facilitate close monitoring of high IPV-susceptible groups, and improve outcomes.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"109 4","pages":"252-260"},"PeriodicalIF":1.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12531637/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145328199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined CA19-9, CA125, and CEA to predict prognosis of patients with intrahepatic cholangiocarcinoma after radical surgery: a retrospective, multi-institutional study. 联合CA19-9、CA125和CEA预测肝内胆管癌根治性手术后患者预后:一项回顾性、多机构研究
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2025-10-01 DOI: 10.4174/astr.2025.109.4.224
Tao Wang, Jun Liu

Purpose: In intrahepatic cholangiocarcinoma (ICC), the interactions among CA19-9, CA125, and CEA are not yet fully understood. This study aims to investigate the relationship between a combined grading system of CA19-9, CA125, and CEA (3C grade) and the prognosis of ICC patients, as well as its predictive capability for prognosis.

Methods: The patients were categorized into different 3C grades based on preoperative serum levels of CA19-9, CA125, and CEA to explore the relationship between 3C grade and overall survival (OS) and recurrence-free survival (RFS), assessing the predictive value of 3C grade for OS and RFS.

Results: A total of 535 eligible patients were included and were classified into different 3C grade groups. Significant differences were observed among different 3C grade groups in clinical characteristics such as tumor size (P = 0.006) and lymph node metastasis (P = 0.006). The Kaplan-Meier curves demonstrated significant differences in OS and RFS among the different 3C grade groups (P < 0.001). The receiver operating characteristic curve analysis revealed that the 3C grade had superior predictive value for OS and RFS compared to individual tumor markers (P < 0.05 for each).

Conclusion: This study revealed that the 3C grade was identified as an independent prognostic factor for OS and RFS after radical surgery of ICC, demonstrating superior predictive value for OS and RFS compared to single tumor markers. The 3C grade model holds promise to assist clinicians in preoperative assessment of ICC patients undergoing radical surgery, thereby aiding in the development of personalized treatment strategies.

目的:在肝内胆管癌(ICC)中,CA19-9、CA125和CEA之间的相互作用尚不完全清楚。本研究旨在探讨CA19-9、CA125、CEA (3C级)联合分级系统与ICC患者预后的关系及其对预后的预测能力。方法:根据术前血清CA19-9、CA125、CEA水平将患者分为不同的3C分级,探讨3C分级与总生存期(OS)和无复发生存期(RFS)的关系,评估3C分级对OS和RFS的预测价值。结果:共纳入535例符合条件的患者,分为不同的3C级组。不同3C级组患者肿瘤大小(P = 0.006)、淋巴结转移(P = 0.006)等临床特征差异有统计学意义。Kaplan-Meier曲线显示,不同3C级组的OS和RFS差异有统计学意义(P < 0.001)。受试者工作特征曲线分析显示,与单项肿瘤标志物相比,3C分级对OS和RFS的预测价值更高(P < 0.05)。结论:本研究发现3C分级是ICC根治性手术后OS和RFS的独立预后因素,与单一肿瘤标志物相比,对OS和RFS的预测价值更高。3C级模型有望帮助临床医生对接受根治性手术的ICC患者进行术前评估,从而帮助制定个性化的治疗策略。
{"title":"Combined CA19-9, CA125, and CEA to predict prognosis of patients with intrahepatic cholangiocarcinoma after radical surgery: a retrospective, multi-institutional study.","authors":"Tao Wang, Jun Liu","doi":"10.4174/astr.2025.109.4.224","DOIUrl":"10.4174/astr.2025.109.4.224","url":null,"abstract":"<p><strong>Purpose: </strong>In intrahepatic cholangiocarcinoma (ICC), the interactions among CA19-9, CA125, and CEA are not yet fully understood. This study aims to investigate the relationship between a combined grading system of CA19-9, CA125, and CEA (3C grade) and the prognosis of ICC patients, as well as its predictive capability for prognosis.</p><p><strong>Methods: </strong>The patients were categorized into different 3C grades based on preoperative serum levels of CA19-9, CA125, and CEA to explore the relationship between 3C grade and overall survival (OS) and recurrence-free survival (RFS), assessing the predictive value of 3C grade for OS and RFS.</p><p><strong>Results: </strong>A total of 535 eligible patients were included and were classified into different 3C grade groups. Significant differences were observed among different 3C grade groups in clinical characteristics such as tumor size (P = 0.006) and lymph node metastasis (P = 0.006). The Kaplan-Meier curves demonstrated significant differences in OS and RFS among the different 3C grade groups (P < 0.001). The receiver operating characteristic curve analysis revealed that the 3C grade had superior predictive value for OS and RFS compared to individual tumor markers (P < 0.05 for each).</p><p><strong>Conclusion: </strong>This study revealed that the 3C grade was identified as an independent prognostic factor for OS and RFS after radical surgery of ICC, demonstrating superior predictive value for OS and RFS compared to single tumor markers. The 3C grade model holds promise to assist clinicians in preoperative assessment of ICC patients undergoing radical surgery, thereby aiding in the development of personalized treatment strategies.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"109 4","pages":"224-234"},"PeriodicalIF":1.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12531636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145328215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative analysis of surgical outcomes of laparoscopic appendectomy performed by six surgeons with different subspecialties: a retrospective cohort study using risk-adjusted cumulative summation. 六名不同亚专科外科医生腹腔镜阑尾切除术手术结果的比较分析:一项采用风险调整累积求和的回顾性队列研究。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2025-09-01 Epub Date: 2025-09-08 DOI: 10.4174/astr.2025.109.3.207
Ji Hyeong Song, Inyoung Na, Song-Yi Kim, Youn Ju Lee, Sun Jong Han, Sang Il Youn, Sa-Hong Min, Jin Soo Kim

Purpose: Laparoscopic appendectomy, a routine surgical procedure for acute appendicitis, is commonly performed in general hospitals. However, postoperative outcomes based on surgical subspecialty have not been well established. This study aimed to compare surgical outcomes of laparoscopic appendectomy across different surgical subspecialties using risk-adjusted cumulative summation (RA-CUSUM) analysis.

Methods: A retrospective analysis was conducted on 631 patients undergoing laparoscopic appendectomy between July 2020 and December 2022. Surgeons were categorized into gastrointestinal (GI) or non-GI groups and senior or young groups. Surgical failure was defined as operation time exceeding the mean plus 2 standard deviations, presence of postoperative complications, or readmission within 30 days after surgery. RA-CUSUM analysis was employed to evaluate surgical failure within each group.

Results: The GI group performed more partial cecectomies (P = 0.017) and had longer operation times (P = 0.019) than the non-GI group. The senior group exhibited shorter operation time (P < 0.001), reduced length of stay (P = 0.011), and a higher complication rate (P < 0.001) than the young group. RA-CUSUM analysis indicated a decrease in surgical failure as accumulation progressed in both senior and young groups, as well as in the GI and non-GI groups.

Conclusion: Outcomes of laparoscopic appendectomy varied by subspecialty and length of experience. However, each surgeon showed trends of decreasing surgical failure over time. These results suggest that the surgeon's subspecialty minimally affects the outcomes of laparoscopic appendectomy, reflecting its fundamental nature within general surgery.

目的:腹腔镜阑尾切除术是治疗急性阑尾炎的一种常规手术方法,在综合医院常用。然而,基于外科亚专科的术后结果尚未得到很好的确定。本研究旨在通过风险调整累积和(RA-CUSUM)分析比较不同外科亚专科腹腔镜阑尾切除术的手术效果。方法:回顾性分析2020年7月至2022年12月行腹腔镜阑尾切除术的631例患者。外科医生分为胃肠道组和非胃肠道组、老年组和青年组。手术失败定义为手术时间超过平均值+ 2个标准差,术后出现并发症,或术后30天内再入院。采用RA-CUSUM分析评价各组手术失败情况。结果:与非GI组相比,GI组切除部分盲肠的次数更多(P = 0.017),手术时间更长(P = 0.019)。老年组手术时间短(P < 0.001),住院时间短(P = 0.011),并发症发生率高于青年组(P < 0.001)。RA-CUSUM分析显示,在老年组和青年组,以及胃肠道组和非胃肠道组,随着积累的进展,手术失败的减少。结论:腹腔镜阑尾切除术的效果因专科和经验长短而异。然而,随着时间的推移,每位外科医生都显示出手术失败减少的趋势。这些结果表明,外科医生的亚专业对腹腔镜阑尾切除术的结果影响最小,反映了其在普通外科中的基本性质。
{"title":"Comparative analysis of surgical outcomes of laparoscopic appendectomy performed by six surgeons with different subspecialties: a retrospective cohort study using risk-adjusted cumulative summation.","authors":"Ji Hyeong Song, Inyoung Na, Song-Yi Kim, Youn Ju Lee, Sun Jong Han, Sang Il Youn, Sa-Hong Min, Jin Soo Kim","doi":"10.4174/astr.2025.109.3.207","DOIUrl":"10.4174/astr.2025.109.3.207","url":null,"abstract":"<p><strong>Purpose: </strong>Laparoscopic appendectomy, a routine surgical procedure for acute appendicitis, is commonly performed in general hospitals. However, postoperative outcomes based on surgical subspecialty have not been well established. This study aimed to compare surgical outcomes of laparoscopic appendectomy across different surgical subspecialties using risk-adjusted cumulative summation (RA-CUSUM) analysis.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 631 patients undergoing laparoscopic appendectomy between July 2020 and December 2022. Surgeons were categorized into gastrointestinal (GI) or non-GI groups and senior or young groups. Surgical failure was defined as operation time exceeding the mean plus 2 standard deviations, presence of postoperative complications, or readmission within 30 days after surgery. RA-CUSUM analysis was employed to evaluate surgical failure within each group.</p><p><strong>Results: </strong>The GI group performed more partial cecectomies (P = 0.017) and had longer operation times (P = 0.019) than the non-GI group. The senior group exhibited shorter operation time (P < 0.001), reduced length of stay (P = 0.011), and a higher complication rate (P < 0.001) than the young group. RA-CUSUM analysis indicated a decrease in surgical failure as accumulation progressed in both senior and young groups, as well as in the GI and non-GI groups.</p><p><strong>Conclusion: </strong>Outcomes of laparoscopic appendectomy varied by subspecialty and length of experience. However, each surgeon showed trends of decreasing surgical failure over time. These results suggest that the surgeon's subspecialty minimally affects the outcomes of laparoscopic appendectomy, reflecting its fundamental nature within general surgery.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"109 3","pages":"207-214"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12457793/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Limited survival benefit of preoperative transarterial chemoembolization in huge hepatocellular carcinoma due to the prognostic impact of satellite nodules: a retrospective cohort study. 一项回顾性队列研究表明,由于卫星结节对预后的影响,术前经动脉化疗栓塞对巨大肝癌患者的生存益处有限。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2025-09-01 Epub Date: 2025-09-08 DOI: 10.4174/astr.2025.109.3.194
Byeong-Gon Na, Shin Hwang, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Sang Hoon Kim, Sung-Gyu Lee

Purpose: Huge (≥10 cm) hepatocellular carcinoma (HCC) poses significant treatment and prognosis challenges. This study aimed to determine whether preoperative transarterial chemoembolization (TACE) for huge HCC is necessary.

Methods: This single-center, retrospective cohort study evaluated 435 patients with huge HCC who underwent upfront hepatectomy or hepatectomy after preoperative TACE from January 2009 to December 2018. TACE's impact on survival and prognostic factors, including microvascular invasion (MVI) and satellite nodules (SNs), was analyzed.

Results: The preoperative TACE group (n = 33) had a lower incidence of MVI (P = 0.009) and higher postoperative morbidity (P = 0.001), particularly pleural effusion (P = 0.004) and Clavien-Dindo class III-IV complications (P = 0.033), compared with the upfront hepatectomy group (n = 402). Short-term mortality (P = 0.828) and recurrence within 6 months (P = 0.654) were comparable between groups. The 1-, 3-, and 5-year survival curves showed no significant between-group differences in recurrence-free survival (RFS) (P = 0.172) and overall survival (OS) (P = 0.450). Local regional therapy for intrahepatic recurrences and surgical resection for extrahepatic recurrences were associated with better OS. MVI, SN, and hepatic vein tumor thrombosis were identified as significant risk factors for poorer RFS and OS. In patients without SN, preoperative TACE improved RFS (P = 0.039) but not OS.

Conclusion: Preoperative TACE for huge HCC was associated with reduced MVI but did not improve RFS and OS. Survival outcomes were more significantly influenced by SN, suggesting that upfront hepatectomy without TACE should be prioritized.

目的:巨大(≥10 cm)的肝细胞癌(HCC)对治疗和预后提出了重大挑战。本研究旨在确定术前经动脉化疗栓塞(TACE)治疗巨大肝癌是否必要。方法:这项单中心、回顾性队列研究评估了2009年1月至2018年12月期间接受术前肝切除术或术前TACE术后肝切除术的435例巨大HCC患者。分析TACE对生存和预后因素的影响,包括微血管侵袭(MVI)和卫星结节(SNs)。结果:与术前肝切除术组(n = 402)相比,术前TACE组(n = 33) MVI发生率较低(P = 0.009),术后发病率较高(P = 0.001),尤其是胸膜积液(P = 0.004)和Clavien-Dindo III-IV级并发症(P = 0.033)。两组间短期死亡率(P = 0.828)和6个月内复发率(P = 0.654)具有可比性。1、3、5年生存曲线显示,组间无复发生存(RFS) (P = 0.172)和总生存(OS) (P = 0.450)无显著差异。肝内复发的局部局部治疗和肝外复发的手术切除与更好的OS相关。MVI、SN和肝静脉肿瘤血栓形成被认为是较差RFS和OS的重要危险因素。在没有SN的患者中,术前TACE改善了RFS (P = 0.039),但没有改善OS。结论:术前TACE治疗巨大肝癌可降低MVI,但不能改善RFS和OS。SN对生存结果的影响更为显著,提示应优先考虑无TACE的前期肝切除术。
{"title":"Limited survival benefit of preoperative transarterial chemoembolization in huge hepatocellular carcinoma due to the prognostic impact of satellite nodules: a retrospective cohort study.","authors":"Byeong-Gon Na, Shin Hwang, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Sang Hoon Kim, Sung-Gyu Lee","doi":"10.4174/astr.2025.109.3.194","DOIUrl":"10.4174/astr.2025.109.3.194","url":null,"abstract":"<p><strong>Purpose: </strong>Huge (≥10 cm) hepatocellular carcinoma (HCC) poses significant treatment and prognosis challenges. This study aimed to determine whether preoperative transarterial chemoembolization (TACE) for huge HCC is necessary.</p><p><strong>Methods: </strong>This single-center, retrospective cohort study evaluated 435 patients with huge HCC who underwent upfront hepatectomy or hepatectomy after preoperative TACE from January 2009 to December 2018. TACE's impact on survival and prognostic factors, including microvascular invasion (MVI) and satellite nodules (SNs), was analyzed.</p><p><strong>Results: </strong>The preoperative TACE group (n = 33) had a lower incidence of MVI (P = 0.009) and higher postoperative morbidity (P = 0.001), particularly pleural effusion (P = 0.004) and Clavien-Dindo class III-IV complications (P = 0.033), compared with the upfront hepatectomy group (n = 402). Short-term mortality (P = 0.828) and recurrence within 6 months (P = 0.654) were comparable between groups. The 1-, 3-, and 5-year survival curves showed no significant between-group differences in recurrence-free survival (RFS) (P = 0.172) and overall survival (OS) (P = 0.450). Local regional therapy for intrahepatic recurrences and surgical resection for extrahepatic recurrences were associated with better OS. MVI, SN, and hepatic vein tumor thrombosis were identified as significant risk factors for poorer RFS and OS. In patients without SN, preoperative TACE improved RFS (P = 0.039) but not OS.</p><p><strong>Conclusion: </strong>Preoperative TACE for huge HCC was associated with reduced MVI but did not improve RFS and OS. Survival outcomes were more significantly influenced by SN, suggesting that upfront hepatectomy without TACE should be prioritized.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"109 3","pages":"194-206"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12457797/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiofrequency ablation for symptomatic, non-functioning thyroid nodules: a single-center retrospective observational study. 射频消融治疗有症状的无功能甲状腺结节:一项单中心回顾性观察研究
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2025-09-01 Epub Date: 2025-09-08 DOI: 10.4174/astr.2025.109.3.144
Huiyin Zhu, Lifen Bai, Ming Zhou, Ling Zhou

Purpose: This study was designed to investigate the efficacy and safety of radiofrequency ablation (RFA) for treating thyroid nodules (TNs).

Methods: We retrospectively included the patients who underwent RFA for TNs in our hospital between January 2020 and December 2023. Preoperative and postoperative data including age, sex, body mass index, and thyroid hormone levels were collected from each patient. The efficacy of RFA on TNs was analyzed by evaluating the volume reduction (VR) and volume reduction rate (VRR) at postoperative months 1, 3, 6, and 12, respectively. In addition, the efficacy of RFA on nodule composition and postoperative complications was evaluated. Finally, a subgroup analysis was conducted to evaluate the potential risks.

Results: VR at postoperative month 12 was significantly higher than those at postoperative months 1, 3, and 6, respectively (all P < 0.001). VRR at month 12 was significantly higher than that of months 1, 3, and 6, respectively (all P < 0.001).

Conclusion: RFA is an effective option for treating TNs with good safety. VR and VRR showed significant increase after RFA compared with the pretreatment levels.

目的:本研究旨在探讨射频消融(RFA)治疗甲状腺结节(TNs)的有效性和安全性。方法:我们回顾性纳入2020年1月至2023年12月期间在我院接受RFA治疗TNs的患者。收集每位患者的术前和术后数据,包括年龄、性别、体重指数和甲状腺激素水平。通过术后1、3、6、12个月的体积缩小(VR)和体积缩小率(VRR)来分析RFA治疗TNs的疗效。此外,我们还评估了RFA对结节组成和术后并发症的影响。最后进行亚组分析,评估潜在风险。结果:术后第12个月的VR明显高于术后第1、3、6个月(均P < 0.001)。第12个月的VRR分别显著高于第1、3、6个月(均P < 0.001)。结论:RFA是治疗TNs的有效选择,安全性好。RFA后的VR和VRR均较前处理水平显著升高。
{"title":"Radiofrequency ablation for symptomatic, non-functioning thyroid nodules: a single-center retrospective observational study.","authors":"Huiyin Zhu, Lifen Bai, Ming Zhou, Ling Zhou","doi":"10.4174/astr.2025.109.3.144","DOIUrl":"10.4174/astr.2025.109.3.144","url":null,"abstract":"<p><strong>Purpose: </strong>This study was designed to investigate the efficacy and safety of radiofrequency ablation (RFA) for treating thyroid nodules (TNs).</p><p><strong>Methods: </strong>We retrospectively included the patients who underwent RFA for TNs in our hospital between January 2020 and December 2023. Preoperative and postoperative data including age, sex, body mass index, and thyroid hormone levels were collected from each patient. The efficacy of RFA on TNs was analyzed by evaluating the volume reduction (VR) and volume reduction rate (VRR) at postoperative months 1, 3, 6, and 12, respectively. In addition, the efficacy of RFA on nodule composition and postoperative complications was evaluated. Finally, a subgroup analysis was conducted to evaluate the potential risks.</p><p><strong>Results: </strong>VR at postoperative month 12 was significantly higher than those at postoperative months 1, 3, and 6, respectively (all P < 0.001). VRR at month 12 was significantly higher than that of months 1, 3, and 6, respectively (all P < 0.001).</p><p><strong>Conclusion: </strong>RFA is an effective option for treating TNs with good safety. VR and VRR showed significant increase after RFA compared with the pretreatment levels.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"109 3","pages":"144-150"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12457796/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgeon's aspect of an expert consensus-based practical recommendation for surgical treatment of hepatocellular carcinoma. 外科医生方面的专家共识为基础的实用建议的手术治疗肝细胞癌。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2025-09-01 Epub Date: 2025-09-08 DOI: 10.4174/astr.2025.109.3.121
Jai Young Cho
{"title":"Surgeon's aspect of an expert consensus-based practical recommendation for surgical treatment of hepatocellular carcinoma.","authors":"Jai Young Cho","doi":"10.4174/astr.2025.109.3.121","DOIUrl":"10.4174/astr.2025.109.3.121","url":null,"abstract":"","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"109 3","pages":"121-122"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12457799/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of glycolytic enzyme expression and thyroiditis on the aggressiveness of papillary thyroid carcinoma: a retrospective cohort study. 糖酵解酶表达和甲状腺炎对甲状腺乳头状癌侵袭性的影响:一项回顾性队列研究。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2025-09-01 Epub Date: 2025-09-08 DOI: 10.4174/astr.2025.109.3.169
Won Woong Kim, Daham Kim, Jin Kyong Kim, Sang-Wook Kang, Jandee Lee, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung

Purpose: Glycolytic enzymes have been extensively studied in various cancer types, revealing their aggressive characteristics and roles in tumor progression. This study aimed to determine whether the expression of glycolytic enzymes is associated with aggressiveness in the presence or absence of chronic lymphocytic thyroiditis (CLT).

Methods: The expression of hexokinase 2, lactate dehydrogenase A (LDHA), pyruvate kinase isoform M2 (PKM2), glucose transporter 1 (GLUT1), and monocarboxylate transporter 4 (MCT4) was examined in 233 papillary thyroid carcinoma (PTC) specimens by immunohistochemistry. We evaluated whether the expression of these glycolytic enzymes correlates with lymph node metastasis, extrathyroidal extension (ETE), and recurrence rate, both with and without CLT. In addition, we analyzed the correlation between glycolytic enzyme messenger RNA expression and risk factors in PTC using The Cancer Genome Atlas.

Results: All glycolytic enzymes and transporter proteins were overexpressed in PTC compared with normal tissue. PKM2 expression was most highly correlated with the other glycolytic enzymes. High PKM2 expression was significantly linked to increased recurrence risk in patients without CLT (hazard ratio, 1.76; 95% confidence interval, 1.01-3.06; P = 0.046), but this association was not observed in those with CLT.

Conclusion: Overexpression of LDHA, PKM2, GLUT1, and MCT4 is associated with PTC. CLT is significantly associated with an increased incidence of gross ETE and, paradoxically, with a reduced recurrence rate in PTC. LDHA expression was lower in the presence of CLT, whereas PKM2 remained consistently linked to a higher recurrence rate in its absence. Among the evaluated glycolytic enzymes, PKM2 may serve as a biomarker for recurrence in PTC.

目的:糖酵解酶在各种类型的肿瘤中被广泛研究,揭示其侵袭性特征及其在肿瘤进展中的作用。本研究旨在确定糖酵解酶的表达是否与慢性淋巴细胞性甲状腺炎(CLT)存在或不存在时的侵袭性有关。方法:采用免疫组化方法检测233例甲状腺乳头状癌(PTC)标本中己糖激酶2、乳酸脱氢酶A (LDHA)、丙酮酸激酶异构体M2 (PKM2)、葡萄糖转运蛋白1 (GLUT1)、单羧酸转运蛋白4 (MCT4)的表达。我们评估了这些糖酵解酶的表达是否与淋巴结转移、甲状腺外展(ETE)和复发率相关,无论是否有CLT。此外,我们利用the Cancer Genome Atlas分析了PTC中糖酵解酶信使RNA表达与危险因素的相关性。结果:与正常组织相比,PTC中所有糖酵解酶和转运蛋白均过表达。PKM2的表达与其他糖酵解酶的表达高度相关。PKM2高表达与无CLT患者复发风险增加显著相关(风险比为1.76;95%可信区间为1.01-3.06;P = 0.046),但在有CLT的患者中未观察到这种关联。结论:LDHA、PKM2、GLUT1、MCT4过表达与PTC相关。CLT与总ETE发生率的增加显著相关,而与PTC复发率的降低矛盾。CLT存在时LDHA表达较低,而PKM2在没有CLT的情况下仍然与较高的复发率有关。在评估的糖酵解酶中,PKM2可能作为PTC复发的生物标志物。
{"title":"The effect of glycolytic enzyme expression and thyroiditis on the aggressiveness of papillary thyroid carcinoma: a retrospective cohort study.","authors":"Won Woong Kim, Daham Kim, Jin Kyong Kim, Sang-Wook Kang, Jandee Lee, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung","doi":"10.4174/astr.2025.109.3.169","DOIUrl":"10.4174/astr.2025.109.3.169","url":null,"abstract":"<p><strong>Purpose: </strong>Glycolytic enzymes have been extensively studied in various cancer types, revealing their aggressive characteristics and roles in tumor progression. This study aimed to determine whether the expression of glycolytic enzymes is associated with aggressiveness in the presence or absence of chronic lymphocytic thyroiditis (CLT).</p><p><strong>Methods: </strong>The expression of hexokinase 2, lactate dehydrogenase A (LDHA), pyruvate kinase isoform M2 (PKM2), glucose transporter 1 (GLUT1), and monocarboxylate transporter 4 (MCT4) was examined in 233 papillary thyroid carcinoma (PTC) specimens by immunohistochemistry. We evaluated whether the expression of these glycolytic enzymes correlates with lymph node metastasis, extrathyroidal extension (ETE), and recurrence rate, both with and without CLT. In addition, we analyzed the correlation between glycolytic enzyme messenger RNA expression and risk factors in PTC using The Cancer Genome Atlas.</p><p><strong>Results: </strong>All glycolytic enzymes and transporter proteins were overexpressed in PTC compared with normal tissue. PKM2 expression was most highly correlated with the other glycolytic enzymes. High PKM2 expression was significantly linked to increased recurrence risk in patients without CLT (hazard ratio, 1.76; 95% confidence interval, 1.01-3.06; P = 0.046), but this association was not observed in those with CLT.</p><p><strong>Conclusion: </strong>Overexpression of LDHA, PKM2, GLUT1, and MCT4 is associated with PTC. CLT is significantly associated with an increased incidence of gross ETE and, paradoxically, with a reduced recurrence rate in PTC. LDHA expression was lower in the presence of CLT, whereas PKM2 remained consistently linked to a higher recurrence rate in its absence. Among the evaluated glycolytic enzymes, PKM2 may serve as a biomarker for recurrence in PTC.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"109 3","pages":"169-184"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12457791/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factor analysis and surgical outcomes in emergency gastrectomy for gastric perforation: a single-center retrospective cohort study. 胃穿孔急诊胃切除术的危险因素分析和手术结果:一项单中心回顾性队列研究。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2025-09-01 Epub Date: 2025-09-08 DOI: 10.4174/astr.2025.109.3.185
Min Hong Lee, Yoon Mo Kim, Mi Kyung Oh, Hyun Il Kim, Min Gyu Kim

Purpose: Gastric perforation remains a life-threatening condition despite advances in medical therapies and surgical techniques. In clinical emergencies involving gastric perforation, distinguishing between benign and malignant etiologies remains uncertain until histological confirmation is obtained.

Methods: This study analyzed 79 patients who underwent emergency gastrectomy for gastric perforation between 2010 and 2024. Patients were categorized into ulcer and cancer groups based on pathological findings. Clinical data, including preoperative conditions and postoperative outcomes, were analyzed using univariate and multivariate analyses.

Results: Elderly (aged ≥75 years), symptom duration ≥48 hours, and American Society of Anesthesiologists physical status classification IV-E were significant risk factors for postoperative mortality. The cancer group had longer operation times, while ventilator use was more common in the ulcer group. No significant differences were observed in overall mortality rates.

Conclusion: Emergency gastrectomy can be a viable treatment for gastric perforation in regions with a high incidence of gastric cancer. However, patients with advanced age, delayed symptom onset, or poor physical status require careful surgical planning. Tailored strategies may improve outcomes, particularly in high-incidence regions for gastric cancer.

目的:尽管医学治疗和手术技术不断进步,胃穿孔仍然是一种危及生命的疾病。在涉及胃穿孔的临床急诊中,在获得组织学证实之前,良恶性病因的区分仍然不确定。方法:本研究分析了2010年至2024年间79例因胃穿孔接受紧急胃切除术的患者。根据病理结果将患者分为溃疡组和癌变组。临床数据,包括术前情况和术后结果,采用单因素和多因素分析进行分析。结果:老年人(≥75岁)、症状持续时间≥48小时、美国麻醉医师协会身体状态分类IV-E是术后死亡率的重要危险因素。肿瘤组手术时间较长,溃疡组呼吸机使用较多。在总死亡率方面没有观察到显著差异。结论:急诊胃切除术是治疗胃癌高发区胃穿孔的可行方法。然而,高龄、症状发作延迟或身体状况不佳的患者需要仔细的手术计划。量身定制的策略可以改善结果,特别是在胃癌高发地区。
{"title":"Risk factor analysis and surgical outcomes in emergency gastrectomy for gastric perforation: a single-center retrospective cohort study.","authors":"Min Hong Lee, Yoon Mo Kim, Mi Kyung Oh, Hyun Il Kim, Min Gyu Kim","doi":"10.4174/astr.2025.109.3.185","DOIUrl":"10.4174/astr.2025.109.3.185","url":null,"abstract":"<p><strong>Purpose: </strong>Gastric perforation remains a life-threatening condition despite advances in medical therapies and surgical techniques. In clinical emergencies involving gastric perforation, distinguishing between benign and malignant etiologies remains uncertain until histological confirmation is obtained.</p><p><strong>Methods: </strong>This study analyzed 79 patients who underwent emergency gastrectomy for gastric perforation between 2010 and 2024. Patients were categorized into ulcer and cancer groups based on pathological findings. Clinical data, including preoperative conditions and postoperative outcomes, were analyzed using univariate and multivariate analyses.</p><p><strong>Results: </strong>Elderly (aged ≥75 years), symptom duration ≥48 hours, and American Society of Anesthesiologists physical status classification IV-E were significant risk factors for postoperative mortality. The cancer group had longer operation times, while ventilator use was more common in the ulcer group. No significant differences were observed in overall mortality rates.</p><p><strong>Conclusion: </strong>Emergency gastrectomy can be a viable treatment for gastric perforation in regions with a high incidence of gastric cancer. However, patients with advanced age, delayed symptom onset, or poor physical status require careful surgical planning. Tailored strategies may improve outcomes, particularly in high-incidence regions for gastric cancer.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"109 3","pages":"185-193"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12457794/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Statistical cure fraction in patients with borderline resectable pancreatic ductal adenocarcinoma undergoing neoadjuvant therapy followed by radical resection: a secondary analysis of reconstructed individual patient data. 边缘性可切除胰导管腺癌患者接受新辅助治疗后根治性切除的统计治愈率:对重建个体患者资料的二次分析。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2025-09-01 Epub Date: 2025-09-08 DOI: 10.4174/astr.2025.109.3.162
Yong Hyun Jang, Ru Ri Lee, Yongkeun Park

Purpose: Although neoadjuvant therapy (NAT) has been applied in patients with borderline resectable pancreatic ductal adenocarcinoma (BR-PDAC), limited data on long-term outcomes are available to support its role as a potentially curable therapeutic option. This study assessed the probability of being statistically cured among these patients.

Methods: The literature search was conducted focusing on previous studies that investigated the long-term recurrence-free survival rates of patients with BR-PDAC after NAT followed by radical resection. The reference cohort data were extracted from studies including patients undergoing upfront radical resection for resectable PDAC. Pseudo-individual patient data were reconstructed from the original papers. A non-mixture cure model was adopted to estimate the statistical cure fraction.

Results: Twelve retrospective studies reporting long-term recurrence-free survival after NAT followed by radical resection for patients with BR-PDAC were secondarily analyzed. The probability of being statistically cured in these patients was 8.1% (95% confidence interval [CI], 5.4%-11.5%), which was lower than that of the reference cohort of 5 retrospective studies (14.7%; 95% CI, 13.2%-16.4%). There was a statistically significant difference between the 2 groups (hazard ratio, 1.110; 95% CI, 1.007-1.224).

Conclusion: From this study, we concluded that a cure can be expected in around eight percent of patients with BR-PDAC after NAT followed by radical resection, which would be helpful in counseling patients, as well as deciding whether to perform the surgery.

目的:虽然新辅助治疗(NAT)已应用于边缘性可切除胰腺导管腺癌(BR-PDAC)患者,但有限的长期结果数据可支持其作为潜在可治愈的治疗选择的作用。这项研究评估了这些患者被治愈的概率。方法:对既往BR-PDAC患者行根治性手术后长期无复发生存率的研究进行文献检索。参考队列数据来自于接受可切除PDAC的前期根治性切除术的患者。伪个体患者数据从原始论文中重建。采用非混合固化模型估计统计固化率。结果:12项回顾性研究报告了BR-PDAC患者在NAT和根治性切除后的长期无复发生存。这些患者的统计学治愈率为8.1%(95%可信区间[CI], 5.4% ~ 11.5%),低于5项回顾性研究的参考队列(14.7%,95% CI, 13.2% ~ 16.4%)。两组间差异有统计学意义(风险比,1.110;95% CI, 1.007-1.224)。结论:从这项研究中,我们得出结论,大约8%的BR-PDAC患者在NAT后根治性切除后可以治愈,这将有助于患者的咨询,以及决定是否进行手术。
{"title":"Statistical cure fraction in patients with borderline resectable pancreatic ductal adenocarcinoma undergoing neoadjuvant therapy followed by radical resection: a secondary analysis of reconstructed individual patient data.","authors":"Yong Hyun Jang, Ru Ri Lee, Yongkeun Park","doi":"10.4174/astr.2025.109.3.162","DOIUrl":"10.4174/astr.2025.109.3.162","url":null,"abstract":"<p><strong>Purpose: </strong>Although neoadjuvant therapy (NAT) has been applied in patients with borderline resectable pancreatic ductal adenocarcinoma (BR-PDAC), limited data on long-term outcomes are available to support its role as a potentially curable therapeutic option. This study assessed the probability of being statistically cured among these patients.</p><p><strong>Methods: </strong>The literature search was conducted focusing on previous studies that investigated the long-term recurrence-free survival rates of patients with BR-PDAC after NAT followed by radical resection. The reference cohort data were extracted from studies including patients undergoing upfront radical resection for resectable PDAC. Pseudo-individual patient data were reconstructed from the original papers. A non-mixture cure model was adopted to estimate the statistical cure fraction.</p><p><strong>Results: </strong>Twelve retrospective studies reporting long-term recurrence-free survival after NAT followed by radical resection for patients with BR-PDAC were secondarily analyzed. The probability of being statistically cured in these patients was 8.1% (95% confidence interval [CI], 5.4%-11.5%), which was lower than that of the reference cohort of 5 retrospective studies (14.7%; 95% CI, 13.2%-16.4%). There was a statistically significant difference between the 2 groups (hazard ratio, 1.110; 95% CI, 1.007-1.224).</p><p><strong>Conclusion: </strong>From this study, we concluded that a cure can be expected in around eight percent of patients with BR-PDAC after NAT followed by radical resection, which would be helpful in counseling patients, as well as deciding whether to perform the surgery.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"109 3","pages":"162-168"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12457792/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative analysis of surgical residency environments between Korea and Türkiye: a cross-sectional study. 韩国和日本外科住院医师环境的比较分析:一项横断面研究。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2025-09-01 Epub Date: 2025-09-08 DOI: 10.4174/astr.2025.109.3.151
Hilal Hwang, Sun Min Lee, Shin-Young Park, Jin Wook Yi, Yun-Mee Choe, Sun Keun Choi

Purpose: Although Korea's medical care uses advanced technology, there are not enough doctors working in rural areas, and fewer doctors are working in challenging fields such as surgery. Medical care in Türkiye is very cost-effective for patients, but doctors have too many patients and too much work. This study compared the healthcare systems of the 2 countries and the gaps felt by surgeons.

Methods: A comparative analysis was conducted using a comprehensive literature review and a questionnaire involving medical professionals from various working positions in both countries.

Results: Doctors in both countries felt that there was a large medical gap between regions and reported that the number of doctors was small. Turkish doctors experience excessive patient overload, contributing to high stress and feelings of overwork. They also showed lower job satisfaction than in Korea. The common reasons for the low preference for general surgery residencies include intense training, excessive workload, and high risk in both countries.

Conclusion: This study identified the key challenges in medical and surgical training in Korea and Türkiye. In Korea, shortages can be addressed by reforms in general surgery residency, the development of a balanced residency selection system, and the provision of work opportunities for non-Korean professionals. In Türkiye, improving remuneration and alleviating unsafe work environments is urgent. Both countries should incentivize rural services to ensure balanced doctor distribution. Collaborative initiatives informed by these findings can enhance medical education and healthcare delivery in both countries.

目的:虽然韩国的医疗保健采用了先进的技术,但在农村地区工作的医生数量不足,在外科等具有挑战性的领域工作的医生更少。缅甸的医疗保健对病人来说非常划算,但医生的病人太多,工作太多。这项研究比较了两国的医疗保健系统和外科医生感受到的差距。方法:采用文献综述和问卷调查的方法,对两国不同工作岗位的医务人员进行比较分析。结果:两国医生均认为地区间医疗差距较大,医生数量较少。土耳其医生的病人负担过重,导致压力过大,感觉工作过度。他们的工作满意度也低于韩国。普通外科住院医师不受欢迎的常见原因包括两国的高强度培训、工作量过大和高风险。结论:本研究确定了韩国和韩国的医疗和外科培训面临的主要挑战。在韩国,可以通过改革普外科住院医师制度、发展均衡的住院医师选拔制度、为非韩国专业人员提供工作机会来解决短缺问题。在乌克兰,提高薪酬和减轻不安全的工作环境迫在眉睫。两国都应该激励农村服务,以确保均衡的医生分配。根据这些发现提出的合作倡议可以加强两国的医学教育和医疗保健服务。
{"title":"Comparative analysis of surgical residency environments between Korea and Türkiye: a cross-sectional study.","authors":"Hilal Hwang, Sun Min Lee, Shin-Young Park, Jin Wook Yi, Yun-Mee Choe, Sun Keun Choi","doi":"10.4174/astr.2025.109.3.151","DOIUrl":"10.4174/astr.2025.109.3.151","url":null,"abstract":"<p><strong>Purpose: </strong>Although Korea's medical care uses advanced technology, there are not enough doctors working in rural areas, and fewer doctors are working in challenging fields such as surgery. Medical care in Türkiye is very cost-effective for patients, but doctors have too many patients and too much work. This study compared the healthcare systems of the 2 countries and the gaps felt by surgeons.</p><p><strong>Methods: </strong>A comparative analysis was conducted using a comprehensive literature review and a questionnaire involving medical professionals from various working positions in both countries.</p><p><strong>Results: </strong>Doctors in both countries felt that there was a large medical gap between regions and reported that the number of doctors was small. Turkish doctors experience excessive patient overload, contributing to high stress and feelings of overwork. They also showed lower job satisfaction than in Korea. The common reasons for the low preference for general surgery residencies include intense training, excessive workload, and high risk in both countries.</p><p><strong>Conclusion: </strong>This study identified the key challenges in medical and surgical training in Korea and Türkiye. In Korea, shortages can be addressed by reforms in general surgery residency, the development of a balanced residency selection system, and the provision of work opportunities for non-Korean professionals. In Türkiye, improving remuneration and alleviating unsafe work environments is urgent. Both countries should incentivize rural services to ensure balanced doctor distribution. Collaborative initiatives informed by these findings can enhance medical education and healthcare delivery in both countries.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"109 3","pages":"151-161"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12457798/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Surgical Treatment and Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1